Anomalous origin of the Left Coronary Artery from the Pulmonary Artery (ALCAPA) syndrome is a rare congenital coronary artery anomaly. There are two types of ALCAPA syndrome: the infant and the adult types, each type presents with different clinical findings and outcomes. In infantile type, infants usually suffer myocardial infarction and congestive heart failure, and about 90% of them die within the first year of life if untreated surgically. In rare instances, ALCAPA syndrome presents in adolescents and adults; it is considered as an important cause of sudden cardiac death. The ideal treatment of ALCAPA syndrome is surgical repair performed by restoration of a dualcoronary-artery system.
INTRODUCTION
he incidence of ALCAPA syndrome is very rare (1 of 300,000 live births) , therefore, it is also known as BlandWhite-Garland-syndrome. Usually, ALCAPA syndrome is an isolated cardiac anomaly which does not manefist prenatally due to favorable fetal physiology that is characterized by equivalent pressures in the aorta and pulmonary artery resulted from a nonrestrictive patent ductus arteriosus (PDA), and the relatively equivalent O 2 saturations resulted from parallel circulations, consequently the perfusion of myocardium will be normal, so that there is no stimulus for the formation of collateral vessels between the right and left coronary artery systems. Shortly after birth, the parallel circulation will be abolished and becomes in one series, the pulmonary artery pressure and pulmonary resistance decrease, and also the O 2 saturation of pulmonary blood flow. Consequently, there will be a decrease in antegrade flow and O 2 saturation of the T anomalous left coronary artery, causing ischemia in myocardium. This results in initiation of collateral circulation between the right and left coronary systems, and reversion of flow in the left coronary artery flow and enters the pulmonary trunk because of the low pulmonary arterial pressure, resulting in what is called coronary steal phenomena that causes a fixed ischemia or myocardial infarction. 85% of all ALCAPA cases present within the first 2 months of life. The clinical presentation and course of ALCAPA include severe left-sided heart failure with significant mitral valve regurgitation due to ischemia of papillary muscle, permanent fibrosis, or left ventricular dilatation. The presentation at late stage is very rare and usually with significant cardiac dysfunction.
[14-16] A case report of a 14 year old girl with ALCAPA syndrome will be discussed.
CASE PRESENTATION
A 14-year-old girl presented with dyspnea and chest pain for two days that was misdiagnosed and treated as a case of musculoskeletal chest pain. She experienced worsening left-sided chest pain and subsequently referred to our cardiac center. She had no coronary risk factors and no family history of premature coronary artery disease or congenital heart disease. Physical examination was unremarkable apart from sinus tachycardia. The long-survival at 20 years was estimated as 94.8%.
[12] The prognosis of ALCAPA syndrome is usually determined by the degree of irreversible left ventricular systolic dysfunction and presence of myocardial scar tissue. Our patient had completely normal left ventricular systolic function two years after surgical repair, which is indicated the absence of irreversible LV systolic dysfunction at the time of diagnosis.
Conclusion:
The diagnosis of ALCAPA syndrome in adolescence and adulthood needs high index of suspicion in patients with left ventricular dysfunction or evidence of ischemic heart disease. 
